Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
havasu78's Profile
Displaying 201-250 of 491 result(s).
CYDY CytoDyn Inc
01/23/2021 3:57:52 PM
Quick google scholar search says ab (1)
CYDY CytoDyn Inc
01/23/2021 3:44:22 PM
Just wondering, why does it take 7 (1)
CYDY CytoDyn Inc
01/19/2021 3:58:09 PM
No effort to deceive. "We asked and (1)
CYDY CytoDyn Inc
01/19/2021 3:24:47 PM
Yes, I was aware that CYDY had cont
CYDY CytoDyn Inc
01/19/2021 3:07:15 PM
So the only way to get to intraveno (1)
CYDY CytoDyn Inc
01/19/2021 1:42:21 PM
Yes, the answer could be as simple (1)
CYDY CytoDyn Inc
01/19/2021 1:25:55 PM
The possibility that intravenous do (4)
CYDY CytoDyn Inc
01/13/2021 6:58:07 PM
yes, my bad, i paraphrased the stud
CYDY CytoDyn Inc
01/13/2021 6:48:02 PM
I agree. Published CCR5delta32 data
CYDY CytoDyn Inc
01/13/2021 6:46:16 PM
Certainly a good point that there a
CYDY CytoDyn Inc
01/13/2021 6:34:13 PM
My theory is that full immunity is
CYDY CytoDyn Inc
01/13/2021 6:23:05 PM
the peer review doesn't matter. the
CYDY CytoDyn Inc
01/13/2021 6:21:41 PM
There are no scientific studies to (1)
CYDY CytoDyn Inc
01/13/2021 6:08:59 PM
Yes, that's the main benefit I see.
CYDY CytoDyn Inc
01/13/2021 5:50:56 PM
That Africa study says "CCR5delta32
CYDY CytoDyn Inc
01/13/2021 5:41:07 PM
Perhaps we disagree as to the need
CYDY CytoDyn Inc
01/13/2021 4:13:48 PM
Thanks much, morokoy. An excellent (1)
CYDY CytoDyn Inc
01/13/2021 4:02:54 PM
Totally agree. In CD12 there are 39 (1)
CYDY CytoDyn Inc
01/13/2021 3:24:15 PM
Yes, CCR5delta32 mutation produces (1)
CYDY CytoDyn Inc
01/13/2021 3:11:37 PM
If CCR5 blockade is completely prot (1)
CYDY CytoDyn Inc
01/13/2021 2:36:41 AM
CCR5delta32 status should also be c (1)
CYDY CytoDyn Inc
01/13/2021 2:30:53 AM
I agree, 8% heterozyzous patients i (1)
CYDY CytoDyn Inc
01/13/2021 2:23:04 AM
No not a waste of time. If you test (4)
CYDY CytoDyn Inc
01/13/2021 2:03:22 AM
Oh sorry i get it now. LOL. protein
CYDY CytoDyn Inc
01/13/2021 1:56:31 AM
CCR5 is a g-coupled protein recepto (2)
CYDY CytoDyn Inc
01/13/2021 1:52:42 AM
Totally agree. all that matters now
CYDY CytoDyn Inc
01/13/2021 1:45:23 AM
"...immune to HIV infection. These
CYDY CytoDyn Inc
01/13/2021 1:34:51 AM
Sure phase 4 would be great for mor (1)
CYDY CytoDyn Inc
01/13/2021 1:28:29 AM
CCR5delta32 homozygous mutants do n
CYDY CytoDyn Inc
01/13/2021 1:21:15 AM
Suggestion to CYDY: Recast LL as a (2)
CYDY CytoDyn Inc
01/13/2021 1:14:36 AM
for all the complaining i have done (2)
CYDY CytoDyn Inc
01/13/2021 1:02:33 AM
Its not 44%, it could be 100%. Mayb (5)
CYDY CytoDyn Inc
01/13/2021 1:01:20 AM
So this study, which demonstrates t (3)
CYDY CytoDyn Inc
01/12/2021 1:46:59 AM
In particular, I think the potentia (2)
CYDY CytoDyn Inc
01/12/2021 1:28:11 AM
I believe CD12 will obtain covid EU (3)
CYDY CytoDyn Inc
01/11/2021 7:29:31 PM
This post by MDV brings to my mind (3)
CYDY CytoDyn Inc
01/11/2021 7:04:22 PM
If CD12 obtains EUA, CD12 RO is tot
CYDY CytoDyn Inc
01/11/2021 6:55:10 PM
It certainly could be true that the
CYDY CytoDyn Inc
01/11/2021 6:13:59 PM
By "squishy", I mean that CD12 prim (3)
CYDY CytoDyn Inc
01/11/2021 2:56:32 PM
Thanks ohm. I can see now that the
CYDY CytoDyn Inc
01/11/2021 1:56:24 PM
If there is no CCR5 RO test being p (2)
CYDY CytoDyn Inc
01/11/2021 4:52:43 AM
CYDY can see 100% of everything in
CYDY CytoDyn Inc
01/10/2021 9:37:06 PM
I remember Patterson saying many mo
CYDY CytoDyn Inc
01/10/2021 8:54:52 PM
CYDY has ALWAYS BEEN UNBLINDED on C (2)
CYDY CytoDyn Inc
01/08/2021 8:25:11 PM
hello to you, too, calstang. I too
CYDY CytoDyn Inc
01/08/2021 8:16:39 PM
No. i think 40 days for the 10Q fil
CYDY CytoDyn Inc
01/08/2021 3:44:03 PM
I think there is was no rush on 10Q
CYDY CytoDyn Inc
01/08/2021 3:39:47 PM
Is 80% power a normal number? And j
CYDY CytoDyn Inc
01/08/2021 3:02:14 PM
LOL. M/M was indeed phase 2. I will
CYDY CytoDyn Inc
01/08/2021 2:56:59 PM
Thanks, ohm. thats all very logical (2)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • MemeCore Unveils $M Token Launch on Top Exchanges
  • Sinopec's Innovative Floating Offshore PV Project Enhances Sustainable Energy
  • Man Group's Interests and Positions on Deliveroo Explained
  • Understanding Recent Securities Disclosures by Ricardo Plc
  • BiyaPay Celebrates Six Innovative Years in Multi-Asset Trading
  • Revolutionizing Trading: Pivex's Innovative Platform Unveiled
  • Atradius Management Restructures for Strategic Growth Ahead
  • Atradius Restructures Management Board for Future Success
  • California's Housing Reforms: A New Era for Urban Growth
  • Forecasting Growth: Sodium Perborate Market Trends Ahead
  • Man Group's Significant Stake in American Axle Under Review
  • Insightful Overview of Recent Dealings by FD Technologies plc
  • Man Group’s Latest Position Disclosure: What You Need to Know
  • IDEX Biometrics Completes Share Consolidation for Growth
  • Understanding Recent Trading Disclosures of Ricardo Plc
  • Understanding the Public Disclosure for Dowlais Group Plc
  • Man Group PLC Discloses Position in Dowlais Group plc Holdings
  • FD Technologies plc: Recent Trading Activities Unveiled
  • Analyzing Employment Trends Amidst Economic Challenges
  • Job Market Resilience Offers Insights into Economic Trends
  • Upcoming Trade Changes as Tariff Pause Approaches Deadline
  • Market Momentum Soars Following Positive Economic Data
  • Exploring ProPicks AI: Revolutionizing Stock Predictions
  • THEON's Strategic Expansion Enhances Baltic Defense Capabilities
  • Cognition Therapeutics (CGTX) Stock Soars Post Alzheimer's Trial Success
  • Market Fluctuations: Impact on Gold and Digital Assets Insights
  • Danske Bank A/S Announces Recent Transactions Report
  • THEON Expands Footprint in the Baltic Defense Market
  • Ivonn Novikova Joins Miss Universe Guyana as Assistant Director
  • Bullish Momentum Persists in S&P 500 Amid Holiday Gains
  • FinSei Ltd and FinHub.cloud Unite for Payment Innovation
  • FinSei Ltd and FinHub.cloud Unite for Payment Innovation in Europe
  • Nxera Pharma Gains Milestone Payments with ORX142 Development
  • Understanding Interest Rate Changes and Refinancing Triggers
  • INVL Technology's Updated Prospectus: What You Need to Know
  • Smartee Denti-Technology Strengthens Academic Ties with Appointment
  • Smartee Denti-Technology Establishes Partnership with Renowned University
  • BlackRock's Significant Stake Increase in Syensqo Explained
  • Bekaert's Strategic Share Buyback and Liquidity Initiatives
  • Electrolux Group Invites You to Their Q2 Results Presentation
  • Electrolux Group Announces Q2 2025 Results Presentation Invitation
  • Author of Bestselling Memoir Faces Legal Challenges Ahead
  • La Rosa Holdings Faces Volatility After Revenue Surge
  • Ping An Good Doctor Leverages AI for Revolutionary Healthcare Solutions
  • Electrolux Group Invites You to Q2 Results Presentation
  • Araris Biotech Team Receives 2025 Strüngmann Award Recognition
  • Bekaert's Commitment to Shareholder Value Through Buybacks
  • Orion Corporation Announces Financial Insights and Upcoming Webcast
  • Investing Insights: NB Private Equity Partners' Share Buyback
  • Eurocastle's Financial Highlights and Strategic Initiatives
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site